The synergistic antinociceptive interactions of endomorphin-1 with dexmedetomidine and/or S(+)-ketamine in rats

G. Horváth, Gabriella Joo, I. Dobos, Walter Klimscha, Geza Toth, G. Benedek

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Spinal administration of the endogenous μ-opioid agonist peptide, endomorphin-1, results in antinociception in rodents, but there are few data about its interaction with other antinociceptive drugs. We investigated the antinociceptive interactions at the spinal level of endomorphin-1 with the N-methyl-D-aspartate antagonist S(+)-ketamine, the α2-adrenoceptor agonist dexmedetomidine, or both in awake rats. Nociception was assessed by the tail-flick test. Dose-response curves were determined for endomorphin-1 (0.6-50/μg), for dexmedetomidine (0.1-10 μg), for mixtures of S(+)-ketamine (30 or 100 μg) with endomorphin-1 (2-18 μg) or of endomorphin-1 with dexmedetomidine in a fixed ratio (4:1), and for the triple combination of the three drugs after intrathecal administration. Endomorphin-1 and dexmedetomidine both produced dose-dependent antinociception. The coadministration of 100 μg S(+)-ketamine significantly enhanced the antinociceptive effect of 6 μg endomorphin-1. Isobolographic analysis of the combinations of endomorphin-1 and dexmedetomidine revealed a synergistic interaction between these drugs. The 80% effective dose for the triple combination was significantly less than that for either binary combination. These data indicate that S(+)-ketamine and dexmedetomidine, acting via different receptors, produce synergistic antinociceptive interaction with endomorphin-1 at the spinal level. Furthermore, the triple combination of an opioid agonist, an α2-adrenoceptor agonist, and an N-methyl-D-aspartate receptor antagonist shows potent antinociceptive activity.

Original languageEnglish
Pages (from-to)1018-1024
Number of pages7
JournalAnesthesia and Analgesia
Volume93
Issue number4
Publication statusPublished - 2001

Fingerprint

Dexmedetomidine
Ketamine
Adrenergic Receptors
endomorphin 1
Nociception
Opioid Peptides
N-Methylaspartate
Drug Combinations
N-Methyl-D-Aspartate Receptors
Drug Interactions
Opioid Analgesics
Tail
Rodentia

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The synergistic antinociceptive interactions of endomorphin-1 with dexmedetomidine and/or S(+)-ketamine in rats. / Horváth, G.; Joo, Gabriella; Dobos, I.; Klimscha, Walter; Toth, Geza; Benedek, G.

In: Anesthesia and Analgesia, Vol. 93, No. 4, 2001, p. 1018-1024.

Research output: Contribution to journalArticle

@article{45c9c0ae527d43349f5000cc18e80d18,
title = "The synergistic antinociceptive interactions of endomorphin-1 with dexmedetomidine and/or S(+)-ketamine in rats",
abstract = "Spinal administration of the endogenous μ-opioid agonist peptide, endomorphin-1, results in antinociception in rodents, but there are few data about its interaction with other antinociceptive drugs. We investigated the antinociceptive interactions at the spinal level of endomorphin-1 with the N-methyl-D-aspartate antagonist S(+)-ketamine, the α2-adrenoceptor agonist dexmedetomidine, or both in awake rats. Nociception was assessed by the tail-flick test. Dose-response curves were determined for endomorphin-1 (0.6-50/μg), for dexmedetomidine (0.1-10 μg), for mixtures of S(+)-ketamine (30 or 100 μg) with endomorphin-1 (2-18 μg) or of endomorphin-1 with dexmedetomidine in a fixed ratio (4:1), and for the triple combination of the three drugs after intrathecal administration. Endomorphin-1 and dexmedetomidine both produced dose-dependent antinociception. The coadministration of 100 μg S(+)-ketamine significantly enhanced the antinociceptive effect of 6 μg endomorphin-1. Isobolographic analysis of the combinations of endomorphin-1 and dexmedetomidine revealed a synergistic interaction between these drugs. The 80{\%} effective dose for the triple combination was significantly less than that for either binary combination. These data indicate that S(+)-ketamine and dexmedetomidine, acting via different receptors, produce synergistic antinociceptive interaction with endomorphin-1 at the spinal level. Furthermore, the triple combination of an opioid agonist, an α2-adrenoceptor agonist, and an N-methyl-D-aspartate receptor antagonist shows potent antinociceptive activity.",
author = "G. Horv{\'a}th and Gabriella Joo and I. Dobos and Walter Klimscha and Geza Toth and G. Benedek",
year = "2001",
language = "English",
volume = "93",
pages = "1018--1024",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The synergistic antinociceptive interactions of endomorphin-1 with dexmedetomidine and/or S(+)-ketamine in rats

AU - Horváth, G.

AU - Joo, Gabriella

AU - Dobos, I.

AU - Klimscha, Walter

AU - Toth, Geza

AU - Benedek, G.

PY - 2001

Y1 - 2001

N2 - Spinal administration of the endogenous μ-opioid agonist peptide, endomorphin-1, results in antinociception in rodents, but there are few data about its interaction with other antinociceptive drugs. We investigated the antinociceptive interactions at the spinal level of endomorphin-1 with the N-methyl-D-aspartate antagonist S(+)-ketamine, the α2-adrenoceptor agonist dexmedetomidine, or both in awake rats. Nociception was assessed by the tail-flick test. Dose-response curves were determined for endomorphin-1 (0.6-50/μg), for dexmedetomidine (0.1-10 μg), for mixtures of S(+)-ketamine (30 or 100 μg) with endomorphin-1 (2-18 μg) or of endomorphin-1 with dexmedetomidine in a fixed ratio (4:1), and for the triple combination of the three drugs after intrathecal administration. Endomorphin-1 and dexmedetomidine both produced dose-dependent antinociception. The coadministration of 100 μg S(+)-ketamine significantly enhanced the antinociceptive effect of 6 μg endomorphin-1. Isobolographic analysis of the combinations of endomorphin-1 and dexmedetomidine revealed a synergistic interaction between these drugs. The 80% effective dose for the triple combination was significantly less than that for either binary combination. These data indicate that S(+)-ketamine and dexmedetomidine, acting via different receptors, produce synergistic antinociceptive interaction with endomorphin-1 at the spinal level. Furthermore, the triple combination of an opioid agonist, an α2-adrenoceptor agonist, and an N-methyl-D-aspartate receptor antagonist shows potent antinociceptive activity.

AB - Spinal administration of the endogenous μ-opioid agonist peptide, endomorphin-1, results in antinociception in rodents, but there are few data about its interaction with other antinociceptive drugs. We investigated the antinociceptive interactions at the spinal level of endomorphin-1 with the N-methyl-D-aspartate antagonist S(+)-ketamine, the α2-adrenoceptor agonist dexmedetomidine, or both in awake rats. Nociception was assessed by the tail-flick test. Dose-response curves were determined for endomorphin-1 (0.6-50/μg), for dexmedetomidine (0.1-10 μg), for mixtures of S(+)-ketamine (30 or 100 μg) with endomorphin-1 (2-18 μg) or of endomorphin-1 with dexmedetomidine in a fixed ratio (4:1), and for the triple combination of the three drugs after intrathecal administration. Endomorphin-1 and dexmedetomidine both produced dose-dependent antinociception. The coadministration of 100 μg S(+)-ketamine significantly enhanced the antinociceptive effect of 6 μg endomorphin-1. Isobolographic analysis of the combinations of endomorphin-1 and dexmedetomidine revealed a synergistic interaction between these drugs. The 80% effective dose for the triple combination was significantly less than that for either binary combination. These data indicate that S(+)-ketamine and dexmedetomidine, acting via different receptors, produce synergistic antinociceptive interaction with endomorphin-1 at the spinal level. Furthermore, the triple combination of an opioid agonist, an α2-adrenoceptor agonist, and an N-methyl-D-aspartate receptor antagonist shows potent antinociceptive activity.

UR - http://www.scopus.com/inward/record.url?scp=0034803998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034803998&partnerID=8YFLogxK

M3 - Article

C2 - 11574376

AN - SCOPUS:0034803998

VL - 93

SP - 1018

EP - 1024

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 4

ER -